Riyadh: Under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, Chairman of the Board of Directors of the Riyadh Biocentral Foundation, Minister of National Guard and Board Member of the Riyadh Biocentral Foundation Prince Abdullah bin Bandar bin Abdulaziz inaugurated the fourth edition of the Riyadh Global Medical Biotechnology Summit today.
According to Saudi Press Agency, the summit is organized by the Ministry of National Guard, represented by Health Affairs, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), and King Abdullah International Medical Research Center (KAIMRC), in partnership with the Ministry of Investment and the Future Investment Initiative Institute as a strategic partner. The summit is being held in Riyadh from September 14 to 16 under the theme "Building the Foundations of Excellence in Medical Biotechnology."
The minister attended the summit's opening session, which brought together prominent leaders, experts, researchers, innovators, and investors in the medical biotechnology sector from around the world.
The summit discusses a number of issues related to the future of medical biotechnology, most notably national strategies and regulatory frameworks, research and development and innovation infrastructure, financing and investment, and human capacity and talent development. It also reviews the latest developments and innovations in the sector.
The summit features more than 100 speakers, including chief executive officers, presidents of leading global universities, experts, and researchers. An accompanying exhibition brings together government, academic, healthcare, technology, industrial, and investment entities to showcase the latest products, services, and advanced medical technologies.
The summit's program includes panel discussions, scientific sessions, specialized workshops, investor and policymaker meetings, and a platform for signing agreements and memoranda of understanding, creating opportunities for cooperation and partnerships in medical biotechnology.